|Articles|December 9, 2022
Migrating a Drug Product from Vial to Pre-Filled Syringe
Author(s)Pfizer CentreOne
This note outlines the benefits of PFS transfer and the key engineering processes required to successfully carry out this process.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Insuring Novel Biologic Development Against Geopolitical Developments: Part Three of Three with Abzena
2
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
3
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
4
Conjugation and Regulation Challenges for Advanced Molecules: Part Two of Three with Abzena
5